Anudeep Sharma

Senior Associate Scientist at Prime Medicine

Anudeep Sharma started working at Prime Medicine, Inc. in 2022 as a Senior Associate Scientist. Prior to that, they worked at Vertex Pharmaceuticals from 2019 to 2022. At Vertex Pharmaceuticals, they held various roles including Analytical Development Senior Research Associate, Analytical Development Research Associate II, Research Associate, and Analytical Development Co-Op.

Anudeep Sharma pursued their education in the field of biotechnology. Anudeep completed their Bachelor of Science (BS) degree in Biotechnology at Devi Ahilya Vishwavidyalaya from 2015 to 2017. Following their undergraduate studies, they went on to pursue a Master of Science (MS) degree in Biotechnology at Northeastern University from 2017 to 2019.

Location

Boston, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Prime Medicine

4 followers

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.


Industries

Employees

51-200

Links